PlainMeds provides educational information only. This is not medical advice. Always consult your doctor or pharmacist.

rolapitant vs rosuvastatin

Side-by-side comparison of rolapitant and rosuvastatin. Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.

minor Known Drug Interaction

Use the lowest effective dose of rosuvastatin (see prescribing information for additional information on recommended dosing).

Recommendation: Use the lowest dose of rosuvastatin that is effective for your condition.

Drug Class
rolapitant NK1 Receptor Antagonist (Antiemetic)
rosuvastatin HMG-CoA Reductase Inhibitor (Statin)
Type
rolapitant Prescription
rosuvastatin Prescription
Summary
rolapitant

Varubi is a medicine that helps prevent nausea and vomiting caused by chemotherapy. It is used with other anti-nausea medicines.

rosuvastatin

Rosuvastatin is a drug that lowers cholesterol. It helps to reduce the risk of heart problems and stroke.

What It Treats
rolapitant

Varubi is used to prevent delayed nausea and vomiting in adults. This nausea and vomiting is caused by cancer chemotherapy. It is used for both the first and repeat treatments of chemotherapy.

rosuvastatin

Rosuvastatin is used to lower bad cholesterol (LDL) in adults and children. It can also slow down the hardening of arteries in adults. This medicine also treats high triglycerides and certain inherited cholesterol disorders.

How It Works
rolapitant

Varubi blocks a substance in your body called substance P/neurokinin 1 (NK1). This substance can cause nausea and vomiting. By blocking it, Varubi helps prevent these side effects from chemotherapy.

rosuvastatin

Rosuvastatin belongs to a class of drugs called statins. It works by blocking a substance your body needs to make cholesterol. This helps to lower your cholesterol levels.

Common Side Effects
rolapitant
  • Neutropenia (low white blood cell count)
  • Hiccups
  • Abdominal pain
  • Decreased appetite
  • Dizziness
rosuvastatin
  • Headache
  • Nausea
  • Muscle pain
  • Weakness
  • Constipation
FAERS Reports
rolapitant
  • Death 141
  • Feeling sick to your stomach 79
  • Feeling tired 50
  • Reaction to the IV medicine 40
  • Difficulty breathing 34
rosuvastatin
  • Tiredness 11,698
  • Feeling sick to your stomach 10,037
  • Difficulty breathing 9,212
  • Loose stools 9,199
  • Muscle pain 8,784
Serious Warnings
rolapitant

You should not take Varubi if you are taking thioridazine or pimozide. These drugs can cause serious heart problems if taken with Varubi. Varubi can increase the levels of these drugs in your blood, leading to QT prolongation and Torsades de Pointes, which are dangerous heart rhythm problems.

rosuvastatin

Rosuvastatin can cause muscle problems, including muscle pain, tenderness, or weakness. Tell your doctor right away if you have these symptoms, especially if you also have a fever or feel sick. Rosuvastatin can also cause liver problems. Your doctor may do blood tests to check your liver before and during treatment.

Pregnancy
rolapitant

There is not enough information about Varubi use in pregnant women to know if it is safe. Talk to your doctor if you are pregnant or plan to become pregnant. It is not known if Varubi passes into breast milk. Talk to your doctor if you are breastfeeding.

rosuvastatin

Do not take rosuvastatin if you are pregnant. It can harm your unborn baby. Talk to your doctor about other ways to control your cholesterol during pregnancy. Breastfeeding is not recommended while taking rosuvastatin.

Also Compare, Nearby Drugs

How to Read This rolapitant vs rosuvastatin Comparison

rolapitant is classified in the NK1 Receptor Antagonist (Antiemetic) drug class, while rosuvastatin sits within the HMG-CoA Reductase Inhibitor (Statin) class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are prescription-only, so a licensed provider must authorize use.

Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, rolapitant has 344 submissions while rosuvastatin has 48,930. Those figures reflect cumulative reporting volume, not per-patient risk, so older, widely dispensed drugs typically look worse on count alone. These two drugs have a known minor interaction flagged in FDA labeling, attributed to rolapitant blocks a protein that helps clear rosuvastatin from your body, which can lead to higher levels of the statin in your blood.. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.

A table cannot substitute for clinical judgment. Effectiveness, tolerability, drug-drug interactions with your other medications, kidney and liver function, pregnancy status, insurance formulary, and price all feed into a decision that only a licensed prescriber can make responsibly. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This page is for educational purposes only, is not medical advice, and should not be used to self-switch between rolapitant and rosuvastatin - always consult your physician or pharmacist first.

Important: This comparison is for informational purposes only. Drug effects vary between individuals. Always consult your doctor or pharmacist for personalized medical advice.